Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Washington for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Washington only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Washington (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Andrew Cheek (NPI 1790979383)

Field	Value
Entity Type	Individual
Organization	Andrew Cheek
Address	427 S Bernard St
City	Spokane
State	WA
ZIP	99204
Taxonomy	Ophthalmology Physician
NPI Enumerated	August 28, 2007

Payer Source	Total Paid
Medicare	$3.5M
Medicaid	$0

Key Findings

This provider’s Medicare business is heavily concentrated in intravitreal anti-VEGF therapy: J0178, J2777, and 67028 together account for 90.3% of total Medicare revenue, indicating the practice is principally delivering high-volume retinal injection services and related minor procedures rather than broad-spectrum ophthalmology care. The presence of multiple drug injection HCPCS codes at the top of the revenue list signals a service-line organized around medical retina treatments, likely age-related macular degeneration and other retinal vascular disease management.

J0178 (aflibercept) is the single largest revenue driver with $1.6M representing 45.2% of Medicare revenue; the provider’s rank of #380/3204 (88th percentile) indicates a solid but not dominant national position for aflibercept administration—volume is typical-to-strong relative to peers. J2777 (faricimab) is also a major revenue source at $1.4M (39.9% of Medicare) and, by contrast, the provider ranks #112/2039 nationally (95th percentile), meaning faricimab administration is a notable strength and an above-typical volume outlier versus national peers.

Clinical support and diagnostics show moderate ancillary activity: 92134 (retinal imaging) generated $72.3K and ranks in the 97th percentile nationally, flagged as an “extreme outlier” in volume; this suggests the practice pairs very high injection volumes with extensive imaging follow-up and monitoring, potentially reflecting a workflow optimized for frequent intravitreal treatment and disease surveillance. The combination of high-volume injections and outsized imaging use implies integrated care pathways for chronic retinal conditions.

Other ophthalmic surgical codes (67042, 67036) and office E/M codes (92014, 92012, 92004, 99204/99205) appear at much smaller shares of revenue (individual codes in the single-digit percent or subpercent ranges), indicating the provider’s practice mix skews away from general comprehensive visits and major vitreoretinal surgery toward office-based injections and related diagnostics. These patterns are consistent with a practice focusing on medical retina rather than primary eye care or high volumes of complex surgery.

Payer mix is effectively single-payer in practical terms: the provider reports $3.5M in lifetime Medicare revenue and has no Medicaid billing on file, so Medicaid does not contribute to observable revenue or service mix. Analysts should treat this entity as Medicare-centric when modeling commercial or public payer mix risk and access implications for low-income populations.

Tenure and stability: the NPI has been enumerated since 2007-08-28 (~19 years ago), indicating long-standing Medicare participation which supports interpretation of these volumes as established practice patterns rather than a short-term or new entrant effect. This longevity, combined with the concentrated code mix, suggests a sustained specialization in retina injections.

Competitive standing is mixed by code: for J2777 the provider is a clear high-volume outlier (95th percentile, rank #112) and for 92134 an extreme outlier (97th percentile), which together imply a localized or networked competitive advantage in delivering faricimab therapy and associated imaging. For J0178 the provider’s national position is good but not exceptional (88th percentile), so while aflibercept services are important, they are not uniquely concentrated compared with peers.

Risk and operational implications: with more than 80% of Medicare revenue coming from two drug codes (J0178 and J2777) and three codes accounting for 90.3% of revenue, the practice has high revenue concentration tied to access to specific pharmaceuticals and protocols for frequent injections. Any changes in drug availability, reimbursement policy, or clinical guidelines for intravitreal agents would disproportionately affect this provider’s revenue and capacity utilization.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

17 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,350	$680	$1.6M
J2777	Injection, faricimab‑svoa, 0.1 mg	48,600	$30	$1.4M
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,900	$100	$184.3K
J2778	Injection, ranibizumab, 0.1 mg	520	$180	$95.2K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,410	$30	$72.3K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	290	$160	$46.5K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	490	$90	$43.9K
67042	In this procedure, the provider removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical cutting tool. He removes the internal limiting membrane of the retina…	30	$860	$27.6K
J7999	Compounded drug, not otherwise classified	210	$70	$14.7K
67036	The provider removes vitreous fluid from the eye to access the posterior segment of the eye and introduce surgical instruments through incisions in the pars plana.	20	$710	$10.7K

Showing 1–10 of 17

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 17 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Washington Distribution

Andrew Cheek — 1 of 17 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Washington

Full comparison — all codes billed, vs. state median

17 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J2777	5	50	12,780	$30	$599.7K
J0178	6	90	470	$680	$597.2K
J2778	12	30	510	$180	$117.1K
67028	9	110	550	$90	$72.9K
J7312	5	20	270	$160	$46K
67042	11	40	30	$1,190	$39.2K
67036	18	20	20	$1,140	$28.6K
92014	91	790	110	$80	$16.8K
J7999	24	70	150	$70	$15.9K
92012	71	220	70	$70	$12.9K

Showing 1–10 of 17

Related Providers

Other providers that share a Tax Identification Number (TIN) with Andrew Cheek, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Spokane Eye Clinic Ps	WA	Multi-Specialty Clinic/Center	$0	$8M
Spokane Eye Clinic Ps	WA	Ambulatory Surgical Clinic/Center	$3M	$716.1K
Robert Wirthlin	WA	Ophthalmology Physician	$3.7M	$0
Dallin Andersen	WA	Ophthalmology Physician	$3.4M	$0
Loren Jack	WA	Ophthalmology Physician	$3.4M	$0
Ryan Whitted	GA	Ophthalmology Physician	$2.5M	$0
Robert Welch	UT	Retina Specialist (Ophthalmology) Physician	$2.5M	$0
Shelly Lee	WA	Ophthalmology Physician	$1.9M	$0
Jessica Weinstein	OR	Retina Specialist (Ophthalmology) Physician	$691.2K	$49.8K
Steven Day	WA	Ophthalmology Physician	$379.5K	$0

Nearby Providers

Other providers in the same ZIP code as Andrew Cheek, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Providence Health & Services - Wa	WA	General Acute Care Hospital	$0	$78.7M
Providence Health & Services Washington	WA	Pulmonary Disease Physician	$0	$78.6M
Multicare Health System	WA	General Acute Care Hospital	$0	$55.1M
New Horizon Care Center, Inc.	WA	Substance Abuse Rehabilitation Facility	$0	$20.2M
Spokane Addiction Recovery Centers	WA	Substance Abuse Rehabilitation Facility	$0	$19M
Spokane Emergency Care Physicians PLLC	WA	Emergency Medicine Physician	$0	$13.9M
Spokane Emergency Physicians, Ps	WA	Emergency Medicine Physician	$0	$13.1M
Providence Health & Services Washington	WA	Clinical Medical Laboratory	$1.6M	$9.3M
Laboratory Corporation Of America	WA	Clinical Medical Laboratory	$1.6M	$6.1M
Integra Imaging, Ps	WA	Diagnostic Radiology Physician	$0	$7.5M

Andrew Cheek — Billing Profile & Reimbursement Data

Sign up for Andrew Cheek — Billing Profile & Reimbursement Data policy alerts

Andrew Cheek — Billing Profile & Reimbursement Data

Sign up for Andrew Cheek — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References